SARS CoV-2 reinfection rate is higher in the Omicron variant than in the Alpha and Delta variants
- PMID: 35711013
- PMCID: PMC9203229
- DOI: 10.1007/s11845-022-03060-4
SARS CoV-2 reinfection rate is higher in the Omicron variant than in the Alpha and Delta variants
Abstract
Background and objectives: Many mutations in variants for instance Delta and Alpha are associated with immune evasion and higher infectious potential. There are uncertainties regarding Omicron. In this regard, we aimed to compare the frequency of reinfection of SARS CoV-2 variants in our hospital between April 22, 2021 and January 26, 2022.
Method: The reinfection rates and demographic characteristics of a total of 27,487 COVID-19 patients infected with different SARS CoV-2 variants were examined.
Results: Reinfection was found in 26 (0.46%) of 5554 Alpha, 209 (1.16%) of 17,941 Delta, and 520 (13.0%) of 3992 Omicron variants. A statistically significant difference was observed between the reinfection rates of the variants (p = 0.000). The mean reinfection days were calculated as 204.4 ± 51.1 in the Alpha variant, 291.2 ± 58.2 in the Delta variant, and 361.2 ± 131.6 in the Omicron variant (p = 0.000). It was observed that 16.5% of reinfection cases caught COVID-19 for the second time 3-6 months after the first COVID-19 infection, 36.7% after 6-12 months, and 46.8% after more than 12 months. There was a significant difference between the times in reinfection cases. Most reinfections occurred more than 12 months apart. Among those with a reinfection time > 12 months, 0% had Alpha, 3.4% had Delta, and 96.6% had Omicron variants.
Conclusion: The highest reinfection rate was observed in the Omicron variant. Reinfection was approximately 30 times more frequent in the Omicron variant than in the Alpha variant and 10 times more frequent in the Delta variant.
Keywords: Alpha; Delta; Omicron; Reinfection; Variant.
© 2022. The Author(s), under exclusive licence to Royal Academy of Medicine in Ireland.
Conflict of interest statement
The authors declare no competing interests.
Figures
Similar articles
-
Prevalence of symptoms, comorbidities, and reinfections in individuals infected with Wild-Type SARS-CoV-2, Delta, or Omicron variants: a comparative study in western Mexico.Front Public Health. 2023 Apr 27;11:1149795. doi: 10.3389/fpubh.2023.1149795. eCollection 2023. Front Public Health. 2023. PMID: 37181688 Free PMC article.
-
Role of previous infection with SARS-CoV-2 in protecting against omicron reinfections and severe complications of COVID-19 compared to pre-omicron variants: a systematic review.BMC Infect Dis. 2023 Jun 26;23(1):432. doi: 10.1186/s12879-023-08328-3. BMC Infect Dis. 2023. PMID: 37365490 Free PMC article.
-
SARS-CoV-2 reinfection with Omicron variant in Shaanxi Province, China: December 2022 to February 2023.BMC Public Health. 2024 Feb 16;24(1):496. doi: 10.1186/s12889-024-17902-6. BMC Public Health. 2024. PMID: 38365671 Free PMC article.
-
SARS-CoV-2 immune response and reinfection in vaccinated Maya and mestizo in Southeast of Mexico.Salud Publica Mex. 2023 Dec 8;66(1, ene-feb):14-16. doi: 10.21149/15186. Salud Publica Mex. 2023. PMID: 38065105
-
Omicron SARS-CoV-2 variant of concern: A review on its transmissibility, immune evasion, reinfection, and severity.Medicine (Baltimore). 2022 May 13;101(19):e29165. doi: 10.1097/MD.0000000000029165. Medicine (Baltimore). 2022. PMID: 35583528 Free PMC article. Review.
Cited by
-
Low Risk of SARS-CoV-2 Reinfection for Fully or Boosted mRNA Vaccinated Subjects in Sicily: A Population-Based Study Using Real-World Data.Vaccines (Basel). 2023 Nov 26;11(12):1757. doi: 10.3390/vaccines11121757. Vaccines (Basel). 2023. PMID: 38140163 Free PMC article.
-
An ecological study on reinfection rates using a large dataset of RT-qPCR tests for SARS-CoV-2 in Santiago of Chile.Front Public Health. 2023 Jul 10;11:1191377. doi: 10.3389/fpubh.2023.1191377. eCollection 2023. Front Public Health. 2023. PMID: 37492136 Free PMC article.
-
Frequency and risk of SARS-CoV-2 reinfections in Norway: a nation-wide study, February 2020 to January 2022.BMC Public Health. 2024 Jan 15;24(1):181. doi: 10.1186/s12889-024-17695-8. BMC Public Health. 2024. PMID: 38225588 Free PMC article.
-
Functional Expression of the Recombinant Spike Receptor Binding Domain of SARS-CoV-2 Omicron in the Periplasm of Escherichia coli.Bioengineering (Basel). 2022 Nov 10;9(11):670. doi: 10.3390/bioengineering9110670. Bioengineering (Basel). 2022. PMID: 36354581 Free PMC article.
-
A brief overview of SARS-CoV-2 infection and its management strategies: a recent update.Mol Cell Biochem. 2024 Sep;479(9):2195-2215. doi: 10.1007/s11010-023-04848-3. Epub 2023 Sep 24. Mol Cell Biochem. 2024. PMID: 37742314 Free PMC article. Review.
References
MeSH terms
Supplementary concepts
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous